Project Number: 1265-32000-082-02
Project Type: Trust

Start Date: Jun 13, 2008
End Date: Jun 12, 2009

Objective:
To evaluate vaccine adjuvants using Neospora caninum antigens in the mouse model of neosporosis.

Approach:
Neospora caninum antigens will be formulated with Pfizer adjuvants and used to immunize the mouse model (BALB/C) of neosporosis. Humoral (antibody respons) and cell-mediated immunities (T cell and cytokine response) of the immunized mice will be determined in vitro.